MedPath

Dexamethasone for Preterm Labour

Phase 2
Completed
Conditions
Prematurity
Interventions
Registration Number
NCT01697098
Lead Sponsor
Assiut University
Brief Summary

The investigators sought to determine whether the incidence of neonatal respiratory distress syndrome (RDS) in preterm fetuses is similar with 12- vs 24-hour dosing interval of dexamethasone.

Detailed Description

The administration of glucocorticoids to accelerate fetal lung maturity in patients with preterm delivery plays an important role for obstetrics and neonatal care. Many studies have shown that maternal administration of glucocorticoids has a significant beneficial effect in decreasing the incidence of respiratory distress syndrome (RDS) in infants delivered at 28-34 weeks of gestation.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • All patient with threatened or established preterm labor between 28 - 34 weeks attended to our emergency unit
Exclusion Criteria
  • emergent obstetric conditions like:

    • Antepartum hemorrhage in severe attack
    • Antepartum eclampsia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
12 hours DexamethasoneDexamethasone 12Those patient will be given 12 hours dexamethasone after randomization
24 hours DexamethasoneDexamethasone 24 hoursThose patient will be give 24 hours dexamethasone after randomization
Primary Outcome Measures
NameTimeMethod
respiratory distress syndrome (RDS)6 month

determine whether the incidence of neonatal respiratory distress syndrome (RDS) is similar with 12- vs 24-hour dosing interval of dexamethasone.

Secondary Outcome Measures
NameTimeMethod
Perinatal mortality6 month

Determine whether the incidence of perinatal mortality is similar with 12- vs 24-hour dosing interval of dexamethasone.

Trial Locations

Locations (1)

Women Health Hospital - Assiut university

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath